WHO ICTRP trial
Phase 1 Clinical Study of JTE-052A - Single and Multiple Dose study -
JPRN-jRCT2080222444 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2080222444 |
|---|---|
| Public title | Phase 1 Clinical Study of JTE-052A - Single and Multiple Dose study - |
| Scientific title | Phase 1 Clinical Study of JTE-052A - Single and Multiple Dose study - |
| Primary sponsor | Japan Tobacco Inc. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 1 |
| Countries | Japan |
| Conditions | healthy volunteers and skin diseases |
| Interventions | investigational material(s) Generic name etc : JTE-052A INN of investigational material : delgocitinib Therapeutic category code : 269 Other agents for epidermis Dosage and Administration for Investigational material : Topical control… |
| Registration date | Mar 28, 2014 |
| Target size | 44 |
| Secondary IDs | JapicCTI-142494 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: